These are exciting times in oncology, but community oncologists need support to keep up with rapidly advancing science, said Lincoln Nadauld.
The study, which will be the pediatric counterpart to the ongoing adult-only NCI-MATCH trial, will be run by the NCI in partnership with the Children's Oncology Group.
The funds from the Sohn Conference Foundation will allow the university to provide sequencing analysis and expertise to kids with cancer to hospitals in the city.
With ProteinPaint, investigators can visualize sequence mutations, gene fusions, and RNA expression to interpret patterns in germline and tumor samples.
The two entities also plan to work together using the data generated from the tests to do added research.
The firm has billed commercial insurers for more than 17,000 tests and reported test results for more than 15,000 Medicare patients without receiving payment.
While the overall number of oncologists who ordered the company's tests in the third quarter did not change, the frequency with which they reordered fell by about 7 percent.
For the second quarter in a row, the company lowered its clinical test volume guidance for 2015 to between 32,000 and 33,000 tests.
The Cologne, Germany-based cancer diagnostics firm plans to use the funds raised to develop a liquid biopsy for its NGS-based NEO platform.
AmoyDx will develop and commercialize a series of oncology tests that use Illumina NGS technology, including the firm's TruSight Tumor 15 panel.
A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.
The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.
Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.
In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.